DarioHealth Corp. Cash Flow Statement
DRIO|5 years of annual SEC 10-K data (FY2014-FY2018)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$11M
FY2018
Free Cash Flow
-$11M
FY2018
Capital Expenditures
$195,000
Cash used for long-term assets
Dividends Paid
N/A
FY2018
DarioHealth Corp. used $11M in operating cash flow and negative free cash flow of $11M in FY2018.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Net Income | -$15.7M | -$10.9M | -$7.1M | -$12.9M | -$13.9M |
| Depreciation & Amortization | $195.0K | $387.0K | $335.0K | $549.0K | $839.0K |
| Operating Cash Flow | -$10.6M | -$8.4M | -$6.3M | -$8.6M | -$7.6M |
| Capital Expenditures | $195.0K | $808.0K | $110.0K | $563.0K | $1.4M |
| Free Cash Flow | -$10.8M | -$9.2M | -$6.4M | -$9.1M | -$9.0M |
| FCF Margin | -209.2% | -327.8% | -776.1% | -17929.4% | - |